UNSPSC 85819125: Transfusion of nonautologous globulin into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous globulin into peripheral artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30253S1

UNSPSC 85819125 Transfusion of nonautologous globulin into peripheral artery, percutaneous approach is a Commodity code that shows little relevant recent activity. The recent state and local opportunities tagged under this code do not align with its nominal scope of blood-product transfusion procedures. Instead, the sourced solicitations span occupational health surveillance, disability medical evaluation, pharmacy benefit management, temporary clinical staffing, surgical care networks, and youth detention medical services — none of which constitute transfusion or globulin administration. The code's narrow clinical definition and the mismatch between the code designation and the actual work being bought suggest either a tagging error in the source data or that this Commodity code does not reflect current state and local procurement demand.

The issuing bodies in the recent records include a state transportation department (Washington State Department of Transportation), county health systems (Santa Clara, Collier County, Harris County), city retirement offices (Phoenix), and a municipal government (Long Beach). Geographic activity spans Washington, Arizona, California, and Texas. Representative recent opportunities include the Washington State Department of Transportation requesting occupational medical surveillance services (RFP20260825, due October 9, 2026) and the City of Phoenix Retirement Office seeking independent medical evaluation services for disability benefit determinations (RTMRFP26001, due October 16, 2026, RFP notice type). Given the code's specificity and the absence of transfusion-related procurement in the current record, pursuit under this code warrants skepticism until recent opportunities can be verified or re-coded to a more appropriate UNSPSC family.